Collectively, pharmaceutical companies invest a vast amount of time and money in intelligence creation, data acquisition and knowledge management. Thousands of R&D professionals engage in research and ‘re-research' as they endeavor to make the best scientific and commercial choices.

Intelligence Networks are a new type of knowledge representation, a format that enables knowledge integration from a wide range of diverse sources in a semantically consistent way so that information can be easily navigated, analyzed, shared and exploited.

Creating Intelligence Networks at the scale and accuracy required to support pharmaceutical business decisions needs a robust methodology, powerful automation and stringent quality control. BioWisdom continues to develop the Sofia environment in partnership with some of the worlds leading pharmaceutical companies where the technology is being exploited to address real-world scientific and commercial issues.

If you are interested in becoming a BioWisdom partner and hearing more about the Sofia environment, please contact sales@biowisdom.com